Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Forbes

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|April 7, 1998
Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biologyR E Banks, M A Forbes, S E Kinsey, et al.
Clinical and Laboratory Haematology|January 1, 1991
Prognostic indicators for the development of AIDS in HIV antibody positive haemophiliac patients: results of a three-year longitudinal studyG M Smith, M A Forbes, J Cooper, et al.
Electrophoresis|May 27, 1999
The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findingsR E Banks, M J Dunn, M A Forbes, et al.
Clinical and Experimental Immunology|October 1, 1995
The acute phase protein response in patients receiving subcutaneous IL-6R E Banks, M A Forbes, M Storr, et al.
British Journal of Cancer|January 1, 1997
Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokinesR E Banks, M A Forbes, S Hallam, et al.
Molecular Human Reproduction|June 10, 1998
Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1R E Banks, M A Forbes, J Searles, et al.
Cytokine|May 11, 2000
Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effectsR E Banks, M A Forbes, P M Patel, et al.
British Journal of Urology|May 1, 1996
A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activationJ K Joffe, R E Banks, M A Forbes, et al.
Cancer Research|June 13, 2000
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifenJ Adams, P J Carder, S Downey, et al.
British Journal of Cancer|January 1, 1997
Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancerG Velikova, R E Banks, A Gearing, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|April 7, 1998
Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biologyR E Banks, M A Forbes, S E Kinsey, et al.
Clinical and Laboratory Haematology|January 1, 1991
Prognostic indicators for the development of AIDS in HIV antibody positive haemophiliac patients: results of a three-year longitudinal studyG M Smith, M A Forbes, J Cooper, et al.
Electrophoresis|May 27, 1999
The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findingsR E Banks, M J Dunn, M A Forbes, et al.
Clinical and Experimental Immunology|October 1, 1995
The acute phase protein response in patients receiving subcutaneous IL-6R E Banks, M A Forbes, M Storr, et al.
British Journal of Cancer|January 1, 1997
Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokinesR E Banks, M A Forbes, S Hallam, et al.
Molecular Human Reproduction|June 10, 1998
Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1R E Banks, M A Forbes, J Searles, et al.
Cytokine|May 11, 2000
Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effectsR E Banks, M A Forbes, P M Patel, et al.
British Journal of Urology|May 1, 1996
A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activationJ K Joffe, R E Banks, M A Forbes, et al.
Cancer Research|June 13, 2000
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifenJ Adams, P J Carder, S Downey, et al.
British Journal of Cancer|January 1, 1997
Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancerG Velikova, R E Banks, A Gearing, et al.
Pageof 4